Your browser doesn't support javascript.
loading
Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas.
William, William N; Tsao, Anne S; Feng, Lei; Ginsberg, Lawrence E; Lee, J Jack; Kies, Merrill S; Glisson, Bonnie S; Kim, Edward S.
  • William WN; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA williamwilliamjr@gmail.com.
  • Tsao AS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Feng L; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ginsberg LE; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee JJ; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kies MS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Glisson BS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kim ES; Levine Cancer Institute, Charlotte, North Carolina, USA.
Oncologist ; 23(5): 526-e49, 2018 05.
Article en En | MEDLINE | ID: mdl-29371473
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Clorhidrato de Erlotinib / Docetaxel / Carcinoma de Células Escamosas de Cabeza y Cuello Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Clorhidrato de Erlotinib / Docetaxel / Carcinoma de Células Escamosas de Cabeza y Cuello Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article